Faculty

Spencer, Thomas, MD

Associate Chief, Pediatric Psychopharmacology Research Program, Massachusetts General Hospital
Associate Professor of Psychiatry, Harvard Medical School

Biography

Dr. Thomas Spencer is an Associate Professor of Psychiatry at Harvard Medical School and the Assistant Chief of the Pediatric Psychopharmacology Research Program at Massachusetts General Hospital. Before joining Massachusetts General Hospital, Dr. Spencer was the Head of the Clinical Team, Child and Adolescent Division, of the Massachusetts Department of Mental Health. His research and clinical interests have focused on the effectiveness and safety of standard and novel pharmacologic treatments of Attention-Deficit/ Hyperactivity Disorder (ADHD) throughout the life-cycle.

Dr. Spencer has been a co-investigator in Dr. Joseph Biederman's longitudinal and family-genetic studies of ADHD. In addition, Dr. Spencer is the Principal Investigator in an NIMH funded project that examines the translation of improvement in ADHD symptoms into increased functional capacities and quality of life in adults with ADHD. Dr. Spencer has published over 90 scientific articles and over 30 book chapters and is on the Editorial Board of a number of Journals.

Disclosure

Research Support:
Shire Laboratories Inc, Cephalon, Eli Lilly & Company, Glaxo-Smith Kline, Janssen, McNeil Pharmaceutical, Novartis Pharmaceuticals, Pfizer, NIMH and the Department of Defense. 

Speaking: 
Shire Laboratories, Inc, Eli Lilly & Company, Glaxo-Smith Kline, Janssen, McNeil Pharmaceutical, Novartis Pharmaceuticals. 

Advisory Board:
Alcobra, Shire Laboratories Inc, Cephalon, Eli Lilly & Company, Glaxo-Smith Kline, Janssen, McNeil Pharmaceutical, Novartis Pharmaceuticals, and Pfizer.

Dr. Spencer has a US Patent Application pending (Provisional Number 61/233,686), through MGH corporate licensing, on a method to prevent stimulant abuse.

Updated 9/24/2012